Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.
暂无分享,去创建一个
O. Jaillon | F. Penin | G. Duverlie | S. Castelain | C. Wychowski | J. Izopet | F. Lunel | H. Khorsi | F. Eb | F. Eb
[1] P. Y. Chou,et al. Prediction of the secondary structure of proteins from their amino acid sequence. , 2006 .
[2] Y. Shiratori,et al. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. , 1997, Journal of virology.
[3] C. Rice,et al. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase , 1997, Journal of virology.
[4] S. Polyak,et al. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b , 1997, Journal of medical virology.
[5] C. Bréchot,et al. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. , 1997, Gastroenterology.
[6] Y. Sasaguri,et al. The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. , 1997, Biochemical and biophysical research communications.
[7] P. Simmonds,et al. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. , 1997, Biochemical and biophysical research communications.
[8] L. Stuyver,et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. , 1997, Journal of hepatology.
[9] P. Simmonds,et al. Virus 'quasispecies': making a mountain out of a molehill? , 1997, The Journal of general virology.
[10] G. Duverlie,et al. Direct blotting electrophoresis for sequencing and genotyping hepatitis C virus. , 1997, Journal of virological methods.
[11] M. Katze,et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.
[12] J. Hoofnagle,et al. The interferon sensitivity determining region: All hepatitis C virus isolates are not the same , 1997, Hepatology.
[13] K. Chayama,et al. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity–determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection , 1997, Hepatology.
[14] S. Zeuzem,et al. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa , 1997, Hepatology.
[15] N. Enomoto,et al. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon‐β therapy , 1997, Hepatology.
[16] J. Hoofnagle,et al. THE TREATMENT OF CHRONIC VIRAL HEPATITIS , 1997 .
[17] K. Shimotohno,et al. The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation , 1997, Journal of virology.
[18] N Enomoto,et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.
[19] P. Marcellin,et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C , 1995, Hepatology.
[20] N. Enomoto,et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. , 1995, The Journal of clinical investigation.
[21] K. Shimotohno,et al. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A , 1995, Journal of virology.
[22] C Geourjon,et al. ANTHEPROT 2.0: a three-dimensional module fully coupled with protein sequence analysis methods. , 1995, Journal of molecular graphics.
[23] M. Tong,et al. Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.
[24] K. Shimotohno,et al. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. , 1994, Biochemical and biophysical research communications.
[25] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[26] H. Hochkeppel,et al. Strong transient expression of the type I interferon–induced MxA protein in hepatitis A but not in acute hepatitis B and C , 1994, Hepatology.
[27] Amos Bairoch,et al. The PROSITE dictionary of sites and patterns in proteins, its current status , 1993, Nucleic Acids Res..
[28] C. Rice,et al. Expression and identification of hepatitis C virus polyprotein cleavage products , 1993, Journal of virology.
[29] S. Zebedee,et al. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[30] N. Kato,et al. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[31] G Deléage,et al. An algorithm for protein secondary structure prediction based on class prediction. , 1987, Protein engineering.
[32] M. Fitzgibbon,et al. Purification and characterization of the NS3 serine protease domain of hepatitis C virus expressed in Saccharomyces cerevisiae. , 1997, The Journal of general virology.
[33] A. Zuckerman,et al. The molecular medicine of viral hepatitis , 1997 .
[34] K Nishikawa,et al. The folding type of a protein is relevant to the amino acid composition. , 1986, Journal of biochemistry.